Skip to main content
. Author manuscript; available in PMC: 2020 May 13.
Published in final edited form as: Curr HIV Res. 2017;15(6):411–421. doi: 10.2174/1570162X15666171120110145

Table 1.

NRTI cellular transport and half-lifes.

NRTI Name Diffusion/SLC Transporter [Ref.] Active ddNTP & ddNDP analogue Plasma Half-Life [Ref.] Inn a cellular half-life [Ref.]
Lamivudine (3TC) OCT1, OCT2, CNT1 [24, 25, 27] 3TC-TP 22 h [26] 15 to 16 h [29]
Emtricitabine (FTC) MATE1 [30] FTC-TP 37 h [31] 39 h [31]
Tenofovir Disoproxil Funiarate (TDF) Direct diffusion [32] TFV-DP ∼17h [33] 164 h [31]
Tenofovir Alafenamide (TAF) Direct diffusion [32] TFV-DP ∼125 h [33] 164 h [31]
Abacavir (ABC) Direct diffusion [18] CBV-TP ∼3.3 [34]h ∼18 to 21 h [35]
Zidovudine (AZT) OAT1-4, CNT1, CNT3, ENT2 AZT-TP ∼2 h [36] ∼9 h [37]
Didanosine (ddI) CNT2, CNT3, ENT1, ENT2 [23, 38] ddI-TP 2.3 h [39] 24 h to 40 h [40]
Stavudine (d4T) CNT1 [41] and. Direct diffusion [19] d4T-TP 7 h [42] 4.5 h [43]

CNT, concentrative nucleoside transporter; ENT, equilibrative nucleoside transporter; MATE, multidrug and toxin extrusion protein; OAT, organic anion transporter; OCT, organic cation transporter.